The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST)
Open accessAbstract
BACKGROUND.: Gastrointestinal stromal tumor (GIST) is the most frequent sarcoma of the intestinal tract and often shows constitutive activation of either the KIT or PDGFRA receptor tyrosine kinases because of gain‐of‐function mutation. Although the efficacy of tyrosine kinase inhibitors in metastatic GIST depends on tumor mutation status, there have been conflicting reports on the prognostic importance of KIT mutation in primary GIST. METHODS.: A total of 127 patients were studied who presented to our institution from 1983 to 2002 with localized primary GIST and underwent complete gross surgical resection of disease. The majority of tumors originated in the stomach (58%) or small intestine (28%). By using polymerase chain reaction (PCR) and direct sequencing, a KIT mutation was found in 71% of patients and a PDGFRA mutation in 6%. RESULTS.: After a median follow‐up of 4.7 years, recurrence‐free survival was 83%, 75%, and 63% at 1, 2, and 5 years, respectively. On multivariate analysis recurrence was predicted by ≥5 mitoses/50 high‐power fields, tumor size ≥10 cm, and tumor location (with patients having small bowel GIST doing the worst). In particular, a high mitotic rate conferred a hazard rate of 14.6 (95% confidence interval, 6.5–32.4). Specific KIT mutations had prognostic importance by univariate but not multivariate analysis. Patients with KIT exon 11 point mutations and insertions had a favorable prognosis. Those with KIT exon 9 mutations or KIT exon 11 deletions involving amino acid W557 and/or K558 had a higher rate of recurrence, whereas patients without a tyrosine kinase mutation had intermediate outcome. CONCLUSIONS.: In the absence of therapy with tyrosine kinase inhibitors, recurrence in completely resected primary GIST is independently predicted by mitotic rate, tumor size, and tumor location. Cancer 2008. © 2007 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Buchdunger, E., Zimmermann, J., Mett, H., Meyer, T., Müller, M., Regenass, U., & Lydon, N. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2558 · Cited by 270
RetractedEfficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
Demetri, G. D., von Mehren, M., Blanke, C. D., Van den Abbeele, A. D., Eisenberg, B., Roberts, P. J., Heinrich, M. C., Tuveson, D. A., Singer, S., Janicek, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020461 · Cited by 4,389
Self-citationEffects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. B. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 2,967
Two Hundred Gastrointestinal Stromal Tumors: Recurrence Patterns and Prognostic Factors for Survival
DeMatteo, R. P., Lewis, J. J., Leung, D., Mudan, S. S., Woodruff, J. M., & Brennan, M. F. (2000) · Annals of Surgery · doi:10.1097/00000658-200001000-00008 · Cited by 2,554
Self-citationPDGFRA Activating Mutations in Gastrointestinal Stromal Tumors
Heinrich, M. C., Corless, C. L., Duensing, A., McGreevey, L., Chen, C.-J., Joseph, N., Singer, S., Griffith, D. J., Haley, A., Town, A., et al. (2003) · Science · doi:10.1126/science.1079666 · Cited by 2,301
Self-citationJoensuu, H., Roberts, P. J., Sarlomo-Rikala, M., Andersson, L. C., Tervahartiala, P., Tuveson, D., Silberman, S. L., Capdeville, R., Dimitrijevic, S., Druker, B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441404 · Cited by 2,037
Verweij, J., Casali, P. G., Zalcberg, J., LeCesne, A., Reichardt, P., Blay, J.-Y., Issels, R., van Oosterom, A., Hogendoorn, P. C., Van Glabbeke, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17098-0 · Cited by 1,665
Miettinen, M., Sobin, L. H., & Lasota, J. (2005) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000146010.92933.de · Cited by 1,249
Debiec-Rychter, M., Sciot, R., Le Cesne, A., Schlemmer, M., Hohenberger, P., van Oosterom, A. T., Blay, J.-Y., Leyvraz, S., Stul, M., Casali, P. G., et al. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.030 · Cited by 892
Antonescu, C. R., Besmer, P., Guo, T., Arkun, K., Hom, G., Koryotowski, B., Leversha, M. A., Jeffrey, P. D., Desantis, D., Singer, S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2245 · Cited by 836
Self-citationPrognosis of Gastrointestinal Smooth-Muscle (Stromal) Tumors: Dependence on Anatomic Site
Emory, T. S., Sobin, L. H., Lukes, L., Lee, D. H., & O'Leary, T. J. (1999) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199901000-00009 · Cited by 625
Debiec-Rychter, M., Cools, J., Dumez, H., Sciot, R., Stul, M., Mentens, N., Vranckx, H., Wasag, B., Prenen, H., Roesel, J., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.020 · Cited by 494
Corless, C. L., McGreevey, L., Haley, A., Town, A., & Heinrich, M. C. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61103-0 · Cited by 444
Effect of c-kit Mutation on Prognosis of Gastrointestinal Stromal Tumors
谷口, 正. (2001) · Cited by 438
Singer, S., Rubin, B. P., Lux, M. L., Chen, C.-J., Demetri, G. D., Fletcher, C. D. �., & Fletcher, J. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.03.095 · Cited by 420
Self-citationAntonescu, C. R., Sommer, G., Sarran, L., Tschernyavsky, S. J., Riedel, E., Woodruff, J. M., Robson, M. E., Maki, R. G., Brennan, M. F., Ladanyi, M., et al. (2003) · PubMed · Cited by 359
Self-citationEffect of c-kit mutation on prognosis of gastrointestinal stromal tumors.
Taniguchi, M., Nishida, T., Hirota, S., Isozaki, K., Ito, T., Nomura, T., Matsuda, H., & Kitamura, Y. (1999) · PubMed · Cited by 356
Chen, L. L., Trent, J. C., Wu, E. F., Fuller, G. N., Ramdas, L., Zhang, W., Raymond, A. K., Prieto, V. G., Oyedeji, C. O., Hunt, K. K., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0085 · Cited by 339
Lasota, J., Dansonka-Mieszkowska, A., Sobin, L. H., & Miettinen, M. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700122 · Cited by 317
Prakash, S., Sarran, L., Socci, N., DeMatteo, R. P., Eisenstat, J., Greco, A. M., Maki, R. G., Wexler, L. H., LaQuaglia, M. P., Besmer, P., et al. (2005) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000157790.81329.47 · Cited by 271
Self-citationSommer, G., Agosti, V., Ehlers, I., Rossi, F., Corbacioglu, S., Farkas, J., Moore, M., Manova, K., Antonescu, C. R., & Besmer, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1037763100 · Cited by 244
Self-citationGastrointestinal Stromal Tumors With KIT Exon 11 Deletions Are Associated With Poor Prognosis
Andersson, J., Bümming, P., Meis–Kindblom, J. M., Sihto, H., Nupponen, N., Joensuu, H., Odén, A., Gustavsson, B., Kindblom, L., & Nilsson, B. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.043 · Cited by 237
Wardelmann, E., Losen, I., Hans, V., Neidt, I., Speidel, N., Bierhoff, E., Heinicke, T., Pietsch, T., Büttner, R., & Merkelbach‐Bruse, S. (2003) · International Journal of Cancer · doi:10.1002/ijc.11323 · Cited by 223
Wong, N. A. C. S., Young, R., Malcomson, R. D. G., Nayar, A. G., Jamieson, L. A., Save, V. E., Carey, F. A., Brewster, D. H., Han, C., & Al‐Nafussi, A. (2003) · Histopathology · doi:10.1046/j.1365-2559.2003.01665.x · Cited by 164
Spritz, R. A., Giebel, L. B., & Holmes, S. A. (1992) · PubMed · Cited by 159
Prognostic Significance of c-kit Mutation in Localized Gastrointestinal Stromal Tumors
Kim, T. W., Lee, H., Kang, Y., Choe, M. S., Ryu, M., Chang, H. M., Kim, J., Yook, J. H., Kim, B. S., & Lee, J. S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0581 · Cited by 149
A Knock-In Mouse Model of Gastrointestinal Stromal Tumor Harboring Kit K641E
Rubin, B. P., Antonescu, C. R., Scott-Browne, J. P., Comstock, M., Gu, Y., Tanas, M. R., Ware, C. B., & Woodell, J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0891 · Cited by 148
Self-citationLasota, J. P., Stachura, J., & Miettinen, M. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700360 · Cited by 140
Lasota, J. P., Dansonka‐Mieszkowska, A., Stachura, T., Schneider‐Stock, R., Kallajoki, M. A., Steigen, S. E., Sarlomo‐Rikala, M., Boltze, C., Kordek, R., Roessner, A., et al. (2003) · Modern Pathology · doi:10.1097/01.mp.0000097365.72526.3e · Cited by 108
Population-based study of the diagnosis and treatment of gastrointestinal stromal tumours
Bümming, P., Ahlman, H. K., Andersson‐Assarsson, J. C., Meis‐Kindblom, J. M., Kindblom, L.-G., & Nilsson, B. (2006) · British journal of surgery · doi:10.1002/bjs.5350 · Cited by 64
Cho, S., Kitadai, Y., Yoshida, S., Tanaka, S., Yoshihara, M., Yoshida, K., & Chayama, K. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.6.1361 · Cited by 53
Gastrointestinal stromal tumours (GISTs): a clinicopathological and molecular study of 66 cases
Koay, M. H. E., Goh, Y.-W., Iacopetta, B. J., Grieu, F., Segal, A., Sterrett, G. F., Platten, M., & Spagnolo, D. V. (2005) · Pathology · doi:10.1080/00313020400023628 · Cited by 52
Iesalnieks, I., Rümmele, P., Dietmaier, W., Jantsch, T., Zülke, C., Schlitt, H. J., Hofstädter, F., & Anthuber, M. (2005) · American Journal of Clinical Pathology · doi:10.1309/akk3-vff6-10cw-m566 · Cited by 52
Prognostic value of KIT mutation in gastrointestinal stromal tumors
Liu, X. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i25.3948 · Cited by 31
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
Demetri, G. D., von Mehren, M., Antonescu, C. R., DeMatteo, R. P., Ganjoo, K. N., Maki, R. G., Pisters, P. W. T., Raut, C. P., Riedel, R. F., Schuetze, S., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0116 · Cited by 1,219
Self-citationGastrointestinal stromal tumour
Rubin, B. P., Heinrich, M. C., & Corless, C. L. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60780-6 · Cited by 1,036
Joensuu, H., Eriksson, M., Sundby Hall, K., Hartmann, J. T., Pink, D., Schütte, J., Ramadori, G., Hohenberger, P., Duyster, J., Al-Batran, S.-E., et al. (2012) · JAMA · doi:10.1001/jama.2012.347 · Cited by 980
Gastrointestinal stromal tumour
Joensuu, H., Hohenberger, P., & Corless, C. L. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60106-3 · Cited by 703
Metadata
- Authors
- DeMatteo, R. P., Gold, J. S., Saran, L., Gönen, M., Liau, K. H., Maki, R. G., Singer, S., Besmer, P., Brennan, M. F., & Antonescu, C. R.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2007-12-12
- Volume
- 112
- Issue
- 3
- Pages
- 608-615
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1985861335
- Cited by
- 503
- References
- 34
- FWCI
- 23.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.